XLAB revenueFY2026$14.82M
- FY YoY
- +111.3%
XLAB revenue was $14.82M for fiscal 2026 (ended Jun 30, 2026), up 111.3% from fiscal 2025.
Exascale Labs Holdings Inc. (XLAB) financials
For fiscal 2026 (ended Jun 30, 2026), Exascale Labs Holdings Inc. reported $14.82M of revenue and -$12.16M of net income.
- Revenue, FY2026
- $14.82M
- Revenue growth, YoY
- +111.3%
- Net income, FY2026
- -$12.16M
- Net margin
- -82.1%
- EPS, diluted, FY2026
- -$8108.26
- Cash
- $2.69M
- P/S
- 4.86
- Market cap
- $72.1M
FY2025FY2026
FY2025FY2026
XLAB revenue and earnings growth
XLAB net incomeFY2026-$12.16M
XLAB net income was -$12.16M for fiscal 2026 (ended Jun 30, 2026), compared with -$7.66M in fiscal 2025.
XLAB EPSFY2026-$8108.26
XLAB diluted EPS was -$8108.26 for fiscal 2026 (ended Jun 30, 2026), compared with -$5106.44 in fiscal 2025.
XLAB free cash flowFY2025-$1.01M
XLAB free cash flow was -$1.01M for fiscal 2025 (ended Jun 30, 2025).
Income statement
| Line item | Jun 30, 2026 | Jun 30, 2025 |
|---|---|---|
| Revenue | $14.82M | $7.02M |
| Cost of revenue | $12.40M | $5.91M |
| Gross profit | $2.42M | $1.11M |
| Research and development | $5.49M | $2.80M |
| Selling, general and admin | $1.23M | $363.0K |
| Operating income | -$4.80M | -$3.04M |
| Pre-tax income | -$12.16M | -$7.66M |
| Net income | -$12.16M | -$7.66M |
| EPS, basic | -$8108.26 | -$5106.44 |
| EPS, diluted | -$8108.26 | -$5106.44 |
| Diluted shares | 1,500 | 1,500 |
Balance sheet
| Line item | Jun 30, 2026 | Jun 30, 2025 |
|---|---|---|
| Cash and equivalents | $2.69M | $4.23M |
| Receivables | $1.15M | $152.5K |
| Current assets | $6.52M | $7.30M |
| Total assets | $6.73M | $7.32M |
| Current liabilities | $31.89M | $20.32M |
| Total liabilities | $31.89M | $20.32M |
| Shareholders' equity | -$25.16M | -$13.00M |
Cash flow
| Line item | Jun 30, 2026 | Jun 30, 2025 |
|---|---|---|
| Operating cash flow | -$2.75M | -$1.01M |
| Capital expenditures | - | $2.1K |
| Free cash flow | - | -$1.01M |
| Investing cash flow | $1.41M | -$2.1K |
| Financing cash flow | -$190.0K | $4.28M |
| Stock-based compensation | $0 | $153.3K |
Key ratios
Source: XBRL data Exascale Labs Holdings Inc. files with the SEC, latest filing dated Sep 28, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
XLAB peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| XLAB | $14.82M | +111.3% | -$12.16M | -82.1% | $72.1M |
| MSFT | $346.44B | +17.9% | $142.63B | 41.2% | $4.05T |
| PLTR | $7.29B | +87.1% | $3.67B | 50.3% | $407.69B |
| ORCL | $71.78B | +21.6% | $18.92B | 26.4% | $362.21B |
| SAP | €36.80B | +7.7% | €7.16B | 19.5% | $291.67B |
| CRWD | $5.40B | +24.3% | $58.46M | 1.1% | $234.05B |
| SHOP | $14.17B | +32.5% | $2.13B | 15.0% | $195.63B |
| CRM | $43.94B | +11.2% | $9.66B | 22.0% | $176.90B |
| NOW | $15.43B | +21.8% | $1.45B | 9.4% | $106.66B |
XLAB FAQ
8 questionsWhat is XLAB revenue?
Exascale Labs Holdings Inc. (XLAB) reported $14.82M of revenue for fiscal 2026 (ended Jun 30, 2026). That is up 111.3% from the year before.Is XLAB profitable?
No. Exascale Labs Holdings Inc. reported a net loss of $12.16M for fiscal 2026 (ended Jun 30, 2026).How much cash and debt does XLAB have?
Exascale Labs Holdings Inc. reported $2.69M in cash and cash equivalents on its most recent balance sheet in SEC filings.How fast is XLAB revenue growing?
Exascale Labs Holdings Inc.'s revenue changed +111.3% in fiscal 2026, to $14.82M.What is XLAB gross margin?
Exascale Labs Holdings Inc.'s gross profit was $2.42M on $14.82M of revenue for fiscal 2026 (ended Jun 30, 2026), a gross margin of 16.3%.What is XLAB earnings per share?
Diluted earnings per share were -$8108.26 for fiscal 2026 (ended Jun 30, 2026), from SEC filings, restated for any stock split those filings show.When did XLAB last report financial results?
The latest statements here come from Exascale Labs Holdings Inc.'s 10-K filed on Sep 28, 2026, covering the period ended Jun 30, 2026.Where does this XLAB financial data come from?
Quantisnow builds these statements from the structured XBRL data Exascale Labs Holdings Inc. files with the SEC. It is provided for information only and is not investment advice.